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Vascular complications are associated with the progressive severity of diabetes, resulting in signiﬁcant morbidity and mortality.
This study quantiﬁes functional vascular parameters and macrovascular structure in a rat model of type 1 diabetes. While there
wasnodiﬀerenceinthesystemicarterialelastance(Ea)with50daysofdiabetes,changeswerenotedintheaortaandfemoralartery
including increased tunica media extracellular matrix content, decreased width of both the media and individual smooth muscle
cell layers, and increased incidence of damaged mitochondria. Extracellular matrix proteins and elastin levels were signiﬁcantly
greater in the aorta of diabetic animals. These diﬀerences correlated with diminished matrix metalloprotease activity in the aorta
of the diabetic animals. In conclusion, diabetes signiﬁcantly altered the structure and ultrastructure of the aorta and femoral artery
before systemic changes in arterial elastance could be detected.
1.Introduction
The worldwide incidence of type 1 diabetes is increasing at
a rate of 3% per year [1]. Macrovascular disease, aﬀecting
large vessels, is still the principal cause of morbidity and
mortality for people with diabetes [2], even as new treat-
ments have greatly decreased the incidence of microvascular
complications associated with retinopathy, nephropathy, and
neuropathy. Since type 1 diabetes is typically diagnosed in
youth and young adults, macrovascular changes occur early
[3] and progress throughout the person’s life [4]. In people
with diabetes, the ability of the macrovessels to respond to
agonists decreases with age [5].
Clinical tools used to assess large vessel pathology
indicate that vessel wall structure and stiﬀness change early
intheprogressionofdiabetes[6].Theseclinicaltoolsinclude
measurement of the intima-media thickness to determine
structural changes while pulse wave velocity assesses arterial
stiﬀness. Changes in both parameters occur early in the
progression of type 1 diabetes and tend to become more
severe with the duration of the disease [7, 8]. Stiﬀness
changes associated with diabetes predominantly aﬀect the
aorta and the proximal arteries. Accordingly, the carotid-
aorto-femoral pulse wave velocity was highly correlated with
the duration of type 1 diabetes in humans [9]. This loss of
vascularcomplianceisapowerfulpredictorofcardiovascular
and all-cause mortality for people with diabetes [10].
A change in arterial mechanical properties can occur
with increased collagen cross-linking as a result of glycation
[11, 12]. In humans, the accumulation of certain advanced
glycationendproductsincreasesthelikelihoodofdeveloping
diabetic complications [13]. Diabetes-induced ultrastruc-
tural changes in streptozotocin-(STZ-) treated animal mod-
els include increased accumulation of extracellular matrix
(ECM) proteins, migration of smooth muscle cells (SMCs),
irregular SMC cytoplasm, and endothelial alterations [14],
which model well the morphological changes observed in
human veins [15].
The purpose of this study was to determine the mor-
phometric characteristics of diabetes-induced abnormalities
of two major vessels, the aorta and the femoral artery, at
an early time point before functional changes were noted
at the systemic level and follow those changes as the disease
progressed.2 Experimental Diabetes Research
2.Methods and Materials
2.1. Animals. Thirty-six male Sprague Dawley rats (Harlan,
Indianapolis, IN) weighing 250–270 grams were divided
into two groups: diabetic and nondiabetic control (n =
18 diabetic and n = 18 control). Diabetes was induced
with intraperitoneal injections of streptozotocin (65mg/kg,
Sigma-Aldrich, St. Louis, MO). Control rats were injected
with a vehicle (citrate buﬀer).
Development of diabetes was determined by observ-
ing blood glucose levels greater than 300mg/dL as mea-
sured by an Accu-Check Advantage glucometer (Boehringer
MannheimCorporation,Indianapolis,IN).Ratbodyweights
a n db l o o dg l u c o s el e v e l sw e r er e c o r d e dw e e k l y .R a t sw e r e
provided free access to food and water, and principles of
institutional laboratory animal care were strictly followed.
The rats were sacriﬁced with an intraperitoneal injection of
pentobarbital.
2.2. Vascular Resistance. Functional evaluation was per-
formed using left ventricular catheterization through the
right carotid artery with a 2 French Millar microtip pressure
volumecatheter(MillarInstruments,Houston,TX)asprevi-
ouslydescribed[16],underketamineandxylazineanesthesia
(80mg/Kg and 10mg/Kg, resp.). Heart rate was monitored
during the procedure. After allowing the pressure volume
(PV) loops to stabilize for 3–5 minutes, steady-state PV
loops were recorded for 1 minute at a sampling rate of 1000
samples per second using Millar Pressure Volume System
(MPVS-400, AD Instruments, Colorado Springs, CO). On
average, 5-6 loops per animal were used for analysis of
arterial elastance using PVAN 3.3 software (ADInstruments,
Colorado Springs, CO). Calibration of the pressure volume
catheter wasperformed per manufacturer’s instructions with
hypertonic saline and fresh heparinized rat blood. A blood
sample was taken from each animal group to calculate the
formula for volume calibration.
2.3. Tissue Procurement. Following animal sacriﬁce, one-to-
two millimeter segments of thoracic aorta and proximal
sections of the femoral artery were immediately resected and
rinsed in ice-cold phosphate-buﬀered saline. Samples were
gathered from the center sections of the vessels and quickly
immersed in ﬁxative at +4◦C.
2.4. Light Microscopy Studies. Samples of thoracic aorta and
femoralarterywereﬁxedin4%paraformaldehydeandstored
at +4◦C. Tissues were processed by rinsing with water before
undergoing dehydration through a graded ethanol series
ending in xylene. Samples were embedded in paraﬃn. Five
micrometer paraﬃn sections were cut and stained with
hematoxylinandeosin(H&E)orMasson’strichrome.Vessels
from three rats in each group were used for calculations.
Digital images were acquired using a Nikon Eclipse TE300
microscope attached to a SPOT 32 system (Diagnostic
Instruments, Inc., Sterling Heights, MI).
All analyses were blinded and completed on digital
images using Adobe Photoshop (Adobe Systems Inc.) or
Scion Image (Scion Corporation). Vessel width was mea-
sured at 10 evenly spaced points along the vessel at 20x.
All other analyses were completed on images taken at
40x magniﬁcation. The SMC layer width was measured
at 10 evenly spaced sites between elastic bands along the
vessel length of all but the ﬁrst and last layers within the
media to eliminate any sectioning artifacts or subsequent
misidentiﬁcation of endothelium or adventitia. Total vessel
area measurement including intima, media, and adventitia
and arterial ECM content was calculated by color analysis
from sections stained with Masson’s trichrome.
2.5. Electron Microscopy Studies. Tissues were ﬁxed in 2%
glutaraldehyde,rinsedinPBSandpostﬁxedwith1%osmium
tetroxide. Rinsing with distilled water was followed with a
graded ethanol dehydration series ending with propylene
oxide. The samples were inﬁltrated using a mixture of
1/2 propylene oxide and 1/2 resin overnight and then
embedded in Epon 812 resin (Electron Microscopy Sciences,
Ft.Washington,PA).One-micron-thicksections ofthe vessel
were examined under the light microscope before 80nm
sections were cut on an LKB Nova Ultratome. Thin sections
were captured on precleaned copper grids and stained using
a double lead stain technique [17] with 0.5% lead citrate
and 7% uranyl acetate. Images were captured from random
tissue sections using a JEM 100 CXII transmission electron
microscope at 80KV.
2.6. Morphometric Analysis. Lipid incidence, mitochondrial
area, and mitochondrial membrane integrity were assessed
from electron microscopy (EM) photomicrographs taken at
ﬁnal magniﬁcations of 8,700x and 21,600x. To assess mito-
chondrial quality, each mitochondrion was graded as intact
or compromised using previously published techniques [18].
This grading system scores the mitochondrial membranes
as completely intact, disrupted outer membrane, disrupted
inner membrane, or disruption of both mitochondrial
membranes. The mitochondrial scoring was completed in
a blinded fashion. Analysis of the nuclei was done at ﬁnal
magniﬁcation of 21,600x.
2.7. Matrix Metalloprotease (MMP) Zymography. Aorta was
removed from a STZ-injected rat at 50 days of diabetes and
∼8mmpiecewascutandrinsedinicecold0.15MNaCl.The
tissue was homogenized using Polytron homogenizer in an
ice-coldextractionbuﬀer(1:3wt/vol)containingthefollow-
ing: 50mM Tris-HCl, pH 7.5, 0.15MNaCl, 10mMCaCl2,
0.05% Brij-35, and 0.02% NaN3. The homogenate were
shaken on cold overnight, then centrifuged at 4◦Cf o r3 0m i n
at 12,000×g and the supernatants were collected. Protein
concentration was measured using Protein Assay Reagent
(Bio-Rad, Hercules, CA).
In [19, 20] Quantitative MMP zymography was per-
formed using previously described procedure. Ten % poly-
acrylamide gel was prepared containing mg/mL gelatin
(Fisher Scientiﬁc, Pittsburg, PA). Aorta extracts (10µgt o t a l
protein) were mixed with sample loading sodium dodecyl
sulfate (SDS) buﬀer without beta-mercaptoethanol and
heating, loaded on the gel, and proteins were separated
electrophoretically.Afterelectrophoresis,thegelwasagitatedExperimental Diabetes Research 3
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Figure 1: Arterial elastance was measured via catheters placed
within the left ventricle. No diﬀerence was detected between the
control and diabetic groups (n = 6/group).
in the washing buﬀer, containing 50mM Tris-HCl, pH 7.5,
5mMCaCl 2,1 µMZnSO 4, 0.02% NaN3, and 2.5% Triton
X-100, for 30min twice at room temperature, to remove
SDS. Subsequently, the gel was kept in the incubation buﬀer,
containing 50mM Tris-HCl, pH 7.5, 5mM CaCl2,1 µM
ZnSO4, and 0.02% NaN3, overnight at 37◦Ct oa l l o wM M P s
to cleave gelatin within the gel. Finally, the gel was stained
with Coomassie Brilliant Blue 250 while agitating for 1h
and destained in water until clear bands were visible. The
intensity of the bands was measured in a negative mode
using Adobe Photoshop and MMP activity was expressed in
arbitrary units. As positive control for zymography, puriﬁed
commercial bacterial collagenase (Gibco BRL, Rockville,
MD) was used.
2.8.DataAnalysis. Quantitativeanalysisoftheultrastructure
wascompletedonphotomicrographstakenfromaminimum
of ﬁve independent regions within a section from each
sample at each magniﬁcation aforementioned. Statistical
analysis using Sigma Stat software (SPSS, Inc.) employed t-
tests for comparison of diabetic and control groups and one
way ANOVA for analysis within groups. When the data did
not meet normality requirements, a Mann-Whitney Rank
S u mt e s tw a se m p l o y e d .A l lb a rg r a p h si l l u s t r a t em e a n± SE.
P value ≤ 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Animal Gravimetry and Glucometry. The body weight of
the STZ-diabetic rats and matched controls was not diﬀerent
at the initiation of the study. The control animals weighed
257.7 ± 2.3gm, while the animals assigned to the diabetic
group weighed 262.2 ± 2.8gm. Over time, both groups of
animals gained weight, but the diabetic group gained less
weight than the controls. At 50 days, the control animals
weighed 452.9 ± 15.8gm and the diabetic rats weighed
327.7 ± 14.4gm,whichwassigniﬁcantlydiﬀerent(P<0.05).
Nonfasting blood glucose levels, while between 101–
113mg/dL in control rats, increased 471% with 50 days of
Table 1: Mean rat blood glucose levels: mean nonfasting blood
glucose levels show elevated readings for the diabetic groups
throughout the duration of the study (n = 16 control and 19
diabetic animals).
Blood glucose Control Diabetic
50 day 112.7 ± 4.7 553.7 ±13.9
∗
100 day 101.1 ± 4.3 513.5 ±23.8
∗
150 day 109.5 ± 3.7 444.1 ±10.9
∗
∗indicates P<0.05.
diabetes, 509% with 100 days of diabetes, and 407% with 150
days of diabetes. The high glucose levels in the diabetic rats
wereconsistentacrosstheweeklymeasurements.Theaverage
blood glucose levels at the time of termination are presented
in Table 1.
3.2. Vascular Physiology. There was no statistical diﬀerence
in resting blood pressure recordings, obtained under anes-
thesia, for the diabetic group compared to the matched
controls. With 50 days of diabetes the mean blood pressure
of the control group was 109.7 ± 2.4mmHg, while the mean
blood pressure of the diabetic group was 105.9 ± 2.1mmHg
(n = 6/group). Blood pressure measurements were not
taken on the 100 or 150 day diabetic animals. There was
also no signiﬁcant diﬀerence in average heart rates between
groups: controls levels were 183 ± 33bpm, while the diabetic
group averaged 205 ± 27bpm (n = 7/group). Arterial
elastance, a standard measure of arterial impedance, and
more speciﬁcally aortic impedance [16], was determined
from PV loops obtained from the left ventricle and showed
no diﬀerence between the groups (Figure 1).
3.3. Vascular Structure. H&E-stained sections illustrated dif-
ferences between diabetic and control vessels in the intima-
media width, and the width and number of SMC layers
(Figures2and3).Thewidthoftheaorticwallwasstatistically
greater in the control rats compared to the diabetic animals
at every time point (Table 2, n = 30 measurements/group
from 6 rats/group). At the same time, the tunica media
width from diabetic rats was signiﬁcantly less than from the
control rats at all three time points (P<0.05) (Figure 3(a)).
Approximately 30–37% of the total area of the aortic wall
was comprised of SMC, and that percentage did not change
with time for either experimental groups (Table 2, n =
25 measurements/group from 4rats/group). In the femoral
artery, the SMC comprised 45–67% of the wall area with the
diabetic group larger only at the 50 day time point (Table 3,
n = 5/group from 3rats/group). The number of SMC layers
in the aorta remained relatively constant at the 50 and 100
days of diabetes, but was signiﬁcantly lower in the 150 day
diabetic group compared to the corresponding controls (P<
0.05) and the other diabetic groups (P<0.05, Figure 3(b)).
The layer numbers were not signiﬁcantly diﬀerent between
any of the three control groups (Figure 3(b)). Consistent
with that result, there was no diﬀerence in the SMC
area compared to the ECM area for the aorta (Table 2).
In general, the femoral arteries had higher values for4 Experimental Diabetes Research
Control Diabetic
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Figure 2: Morphological duration-dependent changes in the aorta of diabetic rats. Control aorta showed a typical H&E staining pattern
with SMCs and elastic layers staining pink (lighter and darker, resp.) while nuclei were purple. At the 150-day time point, the SMC layers
became slightly less deﬁned and the vessel wall was reduced in cross-sectional area. The measured vessel wall width (tunica intima-media
width) is illustrated by the gray arrow in the 100-day control image. An example of the SMC layer width measurements is shown with a solid
black line in the 100 day control image (Magniﬁcation: 40x).
Table 2: Diabetes-induced changes in the aorta: vessel (intima-media) width was measured as shown in Figure 2 and was signiﬁcantly less
with diabetes for each time point. There were no statistical diﬀerences between groups in the total percentage of the vessel wall comprised
by SMCs and the SMC/ECM area (as presented in Figure 3), the area containing heterochromatin, and the invaginations within the nuclear
envelope. The diﬀerences in the amount of ECM were not signiﬁcantly diﬀerent until the 150-day time point.
Duration of diabetes
Experimental group 50 days 100 days 150 days
Control Diabetic Control Diabetic Control Diabetic
Vessel width (mm) 1.75 ±0.01 1.57 ±0.02
P<0.001 1.94 ±0.03 1.39 ±0.04
P<0.001 1.76 ±0.02 1.00 ±0.03
P<0.001
SMC area (percent of vessel wall,
including adventitia) 30.2 ±1.53 3 .3 ±2.33 5 .7 ±1.93 4 .6 ±2.13 6 .9 ±2.83 6 .9 ±2.8
Heterochromatin (% of nuclear area) 42 ±24 8 ±34 6 ±34 3 ±33 9 ±43 8 ±2
Invaginations per nuclear envelope 1.10 ±0.22 1.11 ±0.20 1.08 ±0.30 0.55 ±0.17 0.89 ±0.27 0.82 ±0.22
SMC area/ECM area (ratio) 0.60 ±0.04 0.76 ±0.07 0.99 ±0.21 0.67 ±0.16 0.87 ±0.16 0.87 ±0.03
ECM (percent of vessel wall area) 1.79 ±0.22 1.45 ±0.33 2.4 ±0.26 3.09 ±0.44 6.39 ±0.60 9.72 ±1.49
P<0.024Experimental Diabetes Research 5
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Figure 3: Tunica media characteristics in aorta. (a) The media width was signiﬁcantly reduced in the diabetic aortas when compared to the
control aortas at all three time points (P   0.001, n = 150–165 measurements/group from 6 rats/group). (b) There was no diﬀerence in the
number of SMC layers until 150 days at which time the diabetic aorta showed a reduction in the number of layers compared to the respective
control group (P<0.03) and the other diabetic groups (P<0.01). Asterisks denote statistical diﬀerences between control and diabetic pairs
(n = 10–12 measurements/group). (c) The number of SMCs per media layer was assayed with H&E-stained sections. There was a signiﬁcant
increase in the SMC number/layer in the diabetic rat aortas at 50 and 100 days (P<0.005) but returned to control levels at 150 days of
diabetes (n = 10–12 measurements/group).
Table 3: Diabetes-induced changes in the femoralartery:mimicked the changes in theaortawiththe exception of the SMC/ECMarea which
was statistically higher in the femoral artery of the 50-day diabetic animals, but not in the aorta. Heterochromatin was less in the diabetic
samplesat150-days.Lipiddropletdensitywasstatisticallygreaterinthediabeticgroupat150days.Finallytheelastinbandwidthwasgreater
in the diabetic group throughout the study duration.
Duration of diabetes
Experimental group 50 day 100 day 150 day
Control Diabetic Control Diabetic Control Diabetic
SMC area (percent of
vessel wall) 45.0 ±2.7 62.2 ±3.3
P<0.04 60.8 ±10.64 7 .5 ±2.66 7 .0 ±3.96 2 .7 ±5.3
SMC area/ECM area
(ratio) 0.86 ±0.09 1.73 ±0.24
P<0.009 1.76 ±0.75 0.93 ±0.10 2.17 ±0.30 2.17 ±0.30
Nuclear/cytoplasmic area
(ratio) 0.066 ±0.029 0.066 ±0.022 0.132 ±0.108 0.049 ±0.014 0.031 ±0.012 0.0470 ±0.021
Heterochromatin (% of
nuclear area) 40 ±2 31 ±3
P<0.05 33 ±13 7 ±43 2 ±43 1 ±1
Invaginations per nuclear
envelope 0.24 ±0.16 2.17 ±0.54 1.03 ±0.20 0.50 ±0.25 0.79 ±0.42 3.00 ±1.06
Lipid Droplets/area 0.8889 ±0.3889 2.300 ±0.8825 0.4286 ± 0.1727 1.0417 ±0.2210 1.6667 ±0.3885 3.2857 ±0.6100
P<0.034
Elastin band width 0.9614 ± 0.0336 1.1556 ± 0.0305
P<0.001 0.8764 ± 0.0316 1.0072 ± 0.0302
P<0.01 0.4072 ± 0.0202 0.6662 ± 0.0192
P<0.0016 Experimental Diabetes Research
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Figure 4: Examples of electron micrographs of aorta. (a) EM micrographs (8,700x magniﬁcation) showed a distinct organization of SMCs
within each layer, sandwiched by elastic bands (El). The arrowed line in the 50 day control image illustrates a typical elastic band width
measurement. In the diabetic aorta, patches of SMC disorganization were evident. Nuclei (N) of cells from diabetic animals often appeared
to have a diﬀerent spatial orientation with invaginated membranes (50 days). The cytoplasm (Cy) was more spread out with ﬁnger-like
projectionsinthediabeticsamples.ThematrixsurroundingtheSMCcontainedamixtureofcollagen(Col)andelastin(El).(b)Micrographs
(21,600xmagniﬁcation)showSMCnuclei(N)surroundedbycytoplasm(Cy)eitherrichincytoskeletalﬁbers(clear)asseeninthecontrol
samples, or in secretory vesicles (white ) as noted in the diabetic samples. Mitochondria (m) had an increased incidence of swelling or
disruption in the diabetic samples. The nuclei contained heterochromatin (→) lining the inner nuclear envelope.
the SMC/ECM area ratios than the aortic values, as expected.
The only diﬀerence noted between the control and diabetic
animals from the femoral arteries was at the 50 days and that
was reversed at the 100 and 150 day time points (Table 3).
The number of SMCs per layer, indicative of cellular
proliferation, was signiﬁcantly higher at 50 and 100 days in
the diabetic rats when compared to their respective control
groups (P<0.005) (Figure 3(c)). However at the 150 day
time point, there was a decline in the number of SMCs per
layer in the diabetic group that was signiﬁcantly lower than
the other diabetic groups (P<0.005), and therefore not
signiﬁcantly diﬀerent from the 150 day control samples. The
number of SMC per layer did not change signiﬁcantly in any
of the control groups (Figure 3(c)).
3.4. SMC Ultrastructure. In control animals, aortic SMCs
formed a distinct and nicely organized arrangement
(Figure 4(a)) with an ECM mix of collagen and elastin
surrounding each cell. The SMC layers were sandwiched
between elastic bands. At higher magniﬁcation, SMCs from
control animals displayed elongated nuclei surrounded by
cytoplasm rich in cytoskeletal components with mitochon-
dria that were intact (Figure 4(b)). The nuclei contained
heterochromatin lining the inner nuclear envelope. Some
nuclei had deep invaginations. Visually, the SMC from
diabetic rats exhibited changes in the cytoplasm such as
increased secretory vesicles and rough ER (Figure 4(b)). The
SMCs within each layer were less organized in vessels from
diabetic animals, presenting a fragmented appearance when
compared to the control samples.
An increase in the ratio of nuclear to cytoplasmic area
has been used as a basic indicator of cellular hypertrophy
[21]. Based on this calculation, there were no statistically
signiﬁcant changes suggestive of SMC hypertrophy at 50
or 100 days of diabetes (Figure 5), and the same was true
of the SMCs within the femoral artery (Table 3). With 150
days of diabetes, the ratio of nuclear/cytoplasmic area in the
diabetic aorta was signiﬁcantly higher than samples from
control animals (P<0.05) while it remained unchanged in
the femoral artery (Table 3).
While the shape of the nucleus appeared to change
with extended diabetes (Figure 4, 150 days), certain mor-
phological features within the nucleus were not aﬀected.
The amount of heterochromatin lining the inner nuclear
membrane (measured as % of nuclear area) was not diﬀerent
in the aortic samples with diabetes (Table 2), but there was
less heterochromatin in the diabetic femoral samples at 50
days(Table 3).Thenumberofnuclearinvaginations(deﬁned
as nuclear membrane infoldings of at least 0.4µm in depth)
was not diﬀerent between control and diabetic groups at any
time point and from either aortic or femoral samples (Tables
2 and 3,r e s p . ) .Experimental Diabetes Research 7
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Figure 5: Nuclear/cytoplasmic cross-sectional area. Evaluation
of the electron micrographs demonstrated that the ratio of
nuclear/cytoplasm area remained constant at the 50- and 100-day
time points. At 150 days, the ratio signiﬁcantly increased in the
SMC from the diabetic rats (P<0.05). The change in ratio was
due to a corresponding increase in nuclear area and a subsequent
r e d u c t i o ni nc y t o p l a s ma r e a( n = 26–32 measurements/group for
50 day rats, n = 15 measurements/group for 100 and 150 day rats).
With 150 days of diabetes, signiﬁcant portions of mito-
chondria were swollen or disrupted giving a vacuolated
appearance to the SMC cytoplasm (Figure 4(b)). The state
of the mitochondrial membranes was signiﬁcantly disrupted
in all diabetic groups compared to the corresponding
nondiabetic groups (P<0.005). The percentage of intact
mitochondria was based on previously published methods
of quality assessment [18]. There was progressive disruption
in the mitochondria of tissue samples from control animals
(possiblyduetoaging)from3%at50daysto19%at150days
(Figure 6). Likewise, there was a progressive disruption of
the mitochondria from diabetic aortas from 11% at 50 days
to 60% at 150 days. Analysis of the femoral artery samples
indicated that there was no diabetes-induced disruption
of the mitochondria in any of the groups (n = 800–1000
mitochondria at each time point).
3.5. Lipid Droplet Content. Although there were trends
toward more lipid droplets in the aortas of the 50 and 100
day diabetic rats compared to the respective controls, the
diﬀerence was not statistically signiﬁcant until 150 days (P<
0.01) (Figure 7). The femoral artery samples yielded similar
results with only the 150 day groups showing a statistically
signiﬁcant diﬀerence (Table 3). In control vessels, the lipid
droplet incidence also tended to increase with age becoming
signiﬁcantly greater at 150 days (P<0.05) in contrast to the
other two time points.
3.6.ExtracellularMatrix. Perhapsthemostdramaticchanges
in the diabetic vessels were noted in the ECM. Masson’s
trichrome-stainedsectionsdemonstrateddiﬀerencesinECM
amount found within the SMC layers and in the adven-
Grade 1
Grade 2
Grade 3
Grade 4
50 day
150 day
Control Diabetic
Figure6:Mitochondrialmembranedisruptioninaorta.Mitochon-
dria were graded on the basis of membrane intactness with grade 1
as a completely intact organelle. Grade 2 indicated disruption of the
outer mitochondrial membrane. Grade 3 indicated disruption of
the inner mitochondrial membrane, and grade 4 meant that both
membranes were disrupted. In the SMCs from control animals,
the mitochondria were predominantly intact throughout the course
of the study. In contrast, in the SMCs from the diabetic animals
there were more grade 2–4 mitochondria present at day 50 and
the percentage of disrupted mitochondria grew over the 150 day
diabetes duration until over half of the mitochondria determined
to be grade 3-4. Grade 3 measurements were more rare and shown
as a thin sliver in the diabetic 150-day ﬁgure (n = 821 and 1046
mitochondria for 50-day control and diabetic respectively; n = 418
and 425 for 100-day control and diabetic groups; n = 330 and 446
for 150-day control and diabetic groups).
titia (Figure 8(a)). When compared to controls, the ECM
fractional area found within the tunica media, measured
by grouped color analysis, was signiﬁcantly higher (P<
0.05) in the 150 day diabetic compared to the 50-day group
(Figure 8(b)).
Changes in the area of elastic components were assessed
by measuring the elastic component width (Figure 9(a)),
illustratingincreasedelastinbandwidthintheaorticsamples
from diabetic animals at each time point (P<0.005). These
diﬀerenceswerealsoobservedinthefemoralartery(Table 3).
With age the elastic band area fell in both the control and
diabetic groups of the aortic and femoral samples. The ratio
of the SMC to ECM areas was not statistically diﬀerent in the
diabeticgroupscomparedtovesselsfromthecontrolanimals
(Tables 2 and 3). In the femoral artery, the 50-day diabetic
g r o u ph a dg r e a t e rS M C / E C Ma r e ar a t i o st h a nc o n t r o l s( P<
0.01) and this trend reversed by 100 days. In fact, there was8 Experimental Diabetes Research
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Figure 7: Lipid droplets in aorta. (a) Arrows indicate lipid droplets
in a diabetic aortic sample. (b) The number of lipid droplets within
the aortic SMC increased in the 150 day diabetic and control
animals (
∗P < 0.01). The lipid incidence tended to increase with
age in the control rats, becoming signiﬁcant at 150 days ( #P <
0.02). (n = 47–56 measurements/group from 50 day rats, n =
14–24 measurements/group from 100 day rats, and n = 21–24
measurements/group from 150 day rats).
more ECM area as a percentage of the total vessel area in the
150-day diabetic aorta, but not in the other samples tested
(Table 2, n = 11–13 measurements/group).
In order to determine whether the diabetes-induced
increase in ECM levels noted in Figure 9(a) was due to
greater collagen production or decreased collagen break-
down, activity levels of matrix metalloproteases (MMPs),
enzymes degrading collagen, and other ECM components,
weremeasuredfromthe50-day group. Figure 9(b)illustrates
a representative image of a zymography gel. There was
a 41% decrease in the MMP activity in aortic extracts
from the diabetic rats, compared to respective controls
(Figure 9(c)).
4. Discussion
In this study, structural changes were identiﬁed in the large
vessels of a rat model of type 1 diabetes. The structural
changes were present before any changes in resting blood
pressureorarterialelastanceweredetected.Someofthemost
dramatic changes were found in the width of the media
tunica layer of the vessel walls, in the percentage of intact
mitochondria, deposition of intracellular lipid droplets, and
in the extracellular matrix.
Without diabetes, the structure of the vessels changed
very little over the 100 days monitored. The SMC layer width
increased over time, while the elastic layer width decreased,
thus keeping the media width constant. The quality of mito-
chondria in the SMCs from control animals progressively
worsened over time, suggesting that the changes noted in
the control and diabetic animals were not an artifact of
tissue ﬁxation, but associated with the aging and the disease
process. Most of the changes observed in ultrastructure as a
functionof time werein theextracellularmatrix, particularly
collagen. While the elastin steadily declined, the collagen
content increased over time; an alteration known to increase
vessel stiﬀness. In humans the age-related decline in the
mechanical properties of the aorta and resistance arteries
includes central aortic compliance and pulse wave velocities
[22]. The aortic stiﬀness has been strongly associated with
a g ee v e nw h e na d j u s t e df o rd i ﬀerences in resting blood
pressure [23–25].
Vascular changes associated with diabetes have been
described as accelerated aging [24]. In this study, diabetes
signiﬁcantly altered mitochondrial morphology in the vas-
cular SMC. Similar changes have been reported previously
in vascular endothelial cells from a mouse model of type
1 diabetes [26]. It has been suggested that one of the
underlying mechanisms responsible for diabetes-induced
vascular disease is uncoupled mitochondria, with increased
electron leak and the generation of reactive oxygen species
[27, 28].
Measurements of stiﬀness and vascular compliance
are important measures for people with type 1 diabetes.
Recently, structural changes in the carotid arteries of type
1 diabetics without overt vascular disease were examined
according to age and the duration of diabetes [9]. The
researchers found that intima-media thickness was one of
the ﬁrst parameters to change in the diabetic population. In
fact, increased intima-media thickening has been reported in
children and adolescent with short-term diabetes [29]. This
correlates with our ﬁnding of intima-media thickening even
prior to changes in systemic vascular elastance.
Aortic stiﬀness in people with type 1 diabetes without
hypertension correlated with a decline in brain white matter,
as measured by MRI. In fact aortic stiﬀness predicted
white matter atrophy [30]. In women with type 1 diabetes,
vascular changes in the aorta cause signiﬁcant functional
disorders [31]. Large vessel stiﬀness was highly correlated
with the other complications of type 1 diabetes including
nephropathy, retinopathy, and neuropathy [32]. Several
factorsareimportantinpredictingtheadvancementofaortic
dysfunction in people with diabetes. Age is one of the most
important, as it is an independent predictor of stiﬀness and
pulse wave velocity [9]. In addition, the duration of diabetes
predicts the intima-media cross-sectional area and systolic
blood pressure [9]. However, if a person with type 1 diabetesExperimental Diabetes Research 9
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Figure 8: ECM in aorta. (a) Masson’s trichrome-stained imaged demonstrated that the amount of ECM (blue staining) increased with time
in both control and diabetic aortas (magniﬁcation = 40x). (b) The increase in ECM fractional area was signiﬁcant for the diabetic group at
150 days (P<0.001) and the matched control group ( #P < 0.001) (n = 10–12/group for each time point).
maintains tight glycemic control, arterial elastic properties
can be improved [33].
Most of the diabetic characteristics increased with the
duration of diabetes in our model. However, a few reversed
that trend including the number of SMC SMC/media layer,
which showed a statistical diﬀerence at the 50- and 100-
day mark, but not at 150 days. Caution should be used
when evaluating these changes as only 3 animals per group10 Experimental Diabetes Research
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Figure 9: Extracellular matrix. (a) The elastic band width, mea-
sured from EM sections, was signiﬁcantly higher in all diabetic
samples (
∗P < 0.001) although it followed the control pattern
of decline with age ( #P < 0.05; n = 80 measurements from
6rats/groupfor50day ,n = 100 measurements from 3 rats/group
for 100 day, and n = 60 measurements from 3 rats/group for
150 day). (b) A representative zymography is shown. Zymography
of control and diabetic aortic proteins revealed decreased MMP
activity with diabetes. Bacterial collagenase (5ng/lane) was used as
a positive control (P) for zymography. Molecular weight markers
are indicated to the left. (c) Zymogram quantiﬁcation revealed a
statistically signiﬁcant decline in MMP activity. (n = 3/group). The
band included in the analysis is the most intense, as indicated with
the asterisk.
survived 150 days with uncontrolled diabetes. While the ef-
fectsizewaslargeformostofthediabetic-inducedchangesin
vessel characteristics, a lack of statistical diﬀerence in a small
sample size may not be predictive of a larger population.
One interesting correlation was the drop in blood glucose
levels in the diabetic rats at 150 days. It is possible that
certain morphological features are exquisitely sensitive to the
blood glucose level, thus explaining why some parameters
were not statistically diﬀerent at the late time point. An ad-
ditional explanation for the plateau eﬀect may be in the
generalphysiologicalconditionofthesurvivingdiabetic rats.
Twenty-one weeks (150 days) is an extensive period of time
for an animal to survive with uncontrolled diabetes. Finally,
it is possible that there is truly a cellular plateau or cellular
adaptation at which no further morphological changes can
occur.
Thisstudyassistsindeﬁningthediabetictime-dependent
alterations in macrovascular structure and cellular function.
At the structural level we determined that with the progres-
sion of diabetes, ECM content becomes higher in the media
w h i l es m o o t hm u s c l ec e l ll a y e r sa n dn u m b e ro fs m o o t h
muscle cells per layer decline. Ultrastructural changes show
increased cellular hypertrophy and alterations in mitochon-
dria morphology with diabetes. There was an overall age-de-
pendent increase in media lipid droplets, but with a much
higher incidence in the diabetic animals and an age-de-
pendent change in SMC nuclear morphology not related to
diabetes. How any one of these observations contributes to
the development of diabetic macrovascular disease will keep
the ﬁeld of diabetes vascular research busy for a very long
time.
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